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ABSTRACT 
Objective: This study characterize esters from carnauba crude powder and evaluates its hypoglycemic effect on the treatment of diabetic animals. 
Methods: Groups of diabetic mice were induced by alloxan and treated with Carnauba crude powder. Blood samples were collected to determine 
the glucose serum level.  
Results: The compound was identified and characterized as diester of the 4-methoxycinnamic acid (PCO-C) and presented the hypoglycemic effect 
in the concentrations of 100 and 150 mg/kgbody weight (b.w.) the concentration 150 mg/kg b.w..o.f PCO-C presented the best effect on controlling 
glucose levels (p<0.05),when compared to the reference drug.  
Conclusion: The results indicate that the PCO-C is a promising therapeutic compound with hypoglycemic effect. This action can be justified by the 
presence of the diester of 4- methoxycinnamic acid. 
Keywords: Carnauba wax, Cinnamic acid esters, Diabetes Mellitus. 
 
INTRODUCTION 
Diabetes mellitus (DM) is a chronic progressive metabolic disorder 
characterized by hyperglycemia mainly due to absolute (Type 1 DM) 
or relative (Type 2 DM) deficiency of insulin hormone [1]. 
Complications from DM, such as coronary artery and peripheral 
vascular disease, stroke, diabetic neuropathy, amputations, renal 
failure and blindness are resulting in increasing disability, reduced 
life expectancy and enormous health costs for virtually every society 
[2].T.he total number of people with diabetes is projected to rise 
to366 million in 2030, for all age-groups worldwide. DM is a major 
public health problem in the 21st
Despite great efforts invested in diabetes research, its prevalence 
continues to grow, while current medications do not cover all of the 
symptoms and complications of the disease [4]. The use of medicinal 
plants is an important alternative in the treatment of diseases, 
especially in developing countries [5]. Several plant species have 
been pharmacologically or experimentally used to treat of DM [6, 7]. 
Nowadays, the main substances isolated from plants with 
hypoglycemic action are: terpenoids, alkaloids, coumarins, 
flavonoids and phenolic substances [8]. 
 century [3]. 
The Coperniciacerifera Mart, popularly known as Carnauba, 
Carnaubeira or Carandá, is a native palm tree of the semi-arid region 
of Brazilian northeast, mainly in the States of Ceará and Piauí.T.he 
most used product of the carnauba,the wax that covers the leaves, 
has valuable compounds useful for the pharmaceutical, cosmetic and 
food industries [9, 10, 11, 12]. Under the chemical point of view the 
carnauba wax is composed of a mixture of substances, mostly esters 
[13
MATERIALS AND METHODS 
, 14]. Several studies have shown the hypoglicemic potential of 
esters [15, 16]. Thus, this study aimed to characterizeesters from the 
carnaúba leaf powder and evaluates its hypoglycemic activity 
potential. The Laboratory of Human Biochemistry, at the State 
University of Ceará has been evaluating the potential of extracts and 
substances derived from the Brazilian Northeastern flora, especially 
those with hypoglycemic, hypolipidemic, anti-inflammatory, 
antimicrobial and antioxidant activities. In this study, the 
hypoglycemic effect of PCO-C was evaluated due to its proximal 
structure to esters of gamma-oryzanol, which is reported to have 
hypoglycemic activity in the literature. 
Carnauba Leaf Powder Extract 
The carnauba powder from unopened leaves of the bud of 
Coperniciacerifera Mart. was obtained from Pontes Indústria de 
Ceras Ltd a forty grams (40g) ofCarnauba powder were extracted by 
soaking in 500ml* of heptane: ethylene dichloride (90:10) at room 
temperature.T.he extract was filtered and evaporated in a rotary 
evaporator and the residue was stored at 2-8 °C until use. 
The Carnauba powder extract obtained was placed on a column 
(46cm* x 3.8cm*) of Florisil, 400g (MERCK 60-100 meshes), and 
eluted with 2500ml* of the same solvent solution. The total elate was 
then run into a similar column of activated silica gel and after the column 
was washed with the addition 500ml* of the solvent. Mixture of the 
recovered waxy material showed absorption similar to that of aliphatic 
esters. The silica gel was stripped of the adsorbed residue with 2000ml* 
of 10% isopropanol in heptane. Upon concentration of the elute a 
yellowish solid was obtained [17, 18] and it was named PCO-C. 
Characterization of the PCO-C  
FTIR- measurements were performed with a PEKEIN ELMER FTIR 
instrument. NMR spectra were recorded with a Bruker DRX500 
spectrometer at 500 MHz (1H) using CDCl3 as solvent. TLC analyses 
were made on Silica Gel 60 F254
Acute Oral Toxicity Study  
, (Merck) plates using heptane: ethyl 
acetate (1:1) as mobile phase, and purity of the compounds was 
detected by spraying with 5% phosphomolybidic acid solution 
followed by heating at 120°C. 
PCO-C at the dose range of 500-2000 mg/kg b.w. was orally 
administered to mice and mortality was observed after 14 days. 
Acute toxicity was determined in accordance with the method 
provided by the Organization for Economic Cooperation and 
Development (OECD) guidelines 425 [19]. 
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Healthy male Swiss albino mice (Musmusculus), aged approximately 
seven to eight weeks (weighing 20.0-25.0 g), were used in this study. 
The mice were housed in polypropylene cages, maintained under 
standard laboratory conditions, (i.e. 12:12 hour light and dark cycle; 
at an ambient temperature of 25 ± 3°C). Water and food were given 
ad libitum to the animals. The institutional ethics committee on the 
care and use of animals for experimentation approved the 
experimental protocols (no.90/10). 
Induction of experimental diabetes 
Diabetes was induced in mice after fasting by a single intra-
peritoneal injection of alloxan monohydrate, 150 mg/kg b.w. , 
freshly dissolved in cold sterile normal saline [7]. After 7 days, 
diabetes was confirmed by measuring the serum glucose level. 
Animals with blood glucose levels of more than 180 mg/dl were 
considered diabetic. 
According with Jain and Arya 
Group 5: mice diabetic were administered Glibenclamide (10mg/kg 
b.w. /day) in distilled water as a fine aqueous suspensor orally. 
[20] and Misra and Aiman [21], there 
are many inconsistencies and anomalies in alloxan-induced diabetic 
models. These observations have been reported in others studies, 
which indicate that alloxan-induced diabetic model is a doubtful 
model for antidiabetic studies. Hence, further studies are needed to 
evaluate an antidiabetic ideal model. This, however, remains 
contradictory to many other studies where alloxan has been 
successfully used, included the present study.  
Experimental Protocol 
Animals were divided into five groups of 12 mice each. The animals 
of all groups received the doses orally for 21 consecutive days, 
according to the adapted protocol [22]. 
Group 1: mice served as normal-control and received the vehicle 
(0,2 ml distilled water/day/mice); 
Group 2: mice served as diabetic-control and received the vehicle 
(0,2 ml distilled water/day/mice); 
Group 3: mice diabetic were administered PCO-C (100mg/kg b.w. 
/day) in distilled water as a fine aqueous suspensor orally;  
Group 4: mice diabetic were administered PCO-C (150mg/kg b.w. 
/day) in distilled water as a fine aqueous suspensor orally;  
Determination of blood glucose 
Blood samples were collected from the retro-orbital plexus with the 
use of capillary tubes under mild ether anesthesia from overnight 
fasted mice. Blood glucose levels were analyzed on days 0, 10 and 21 
of the study, which was performed by the machine METROLAB 2300 
PLUS VERSION 1.7, which uses the kinetic method for the analysis of 
serum samples. 
Statistical analysis 
The data were expressed as mean ± SEM. One-way analysis of 
variance (ANOVA) and Student-Newman-Keuls test was carried out 
for comparing results among treatments. The significant level was 
set at p<0.05 
RESULTS 
The PCO-C was obtained and characterized according to previously 
described methodology [17, 18], with 7% yield in relation to the 
carnauba powder. The PCO-C was identified as diester of the 4-
methoxycinnamic acid by means of infrared spectroscopic analysis 
(FTIR), thin layer chromatography (TLC) melting point 94-95 °C, 
1HNMR and comparisons to the literature data [17, 18]. By the 
analysis of FTIR spectra of PCO-C, was possible to confirm the 
presence of the following characteristic functional groups: ester 
(1735 cm-1, 1717 cm-1, 1169 cm-1), unsaturation (1630 cm-1, 930 cm-
1), aromatic p-substituted (827 cm-1) and the aromatic p-methoxy 
(1020 cm-1).T.LC analysis of PCO-C and its hydrolysis products 
(saponifiable and unsaponifiable material) corroborate the results 
obtained with FTIR of PCO-C,and in the chromatogram obtained 
with saponifiable material was confirmed that this material contains 
4-methoxycinnamic acid (RF 0.41) and its presence in thePCO-C 
structure was confirmed by 1
Chemical Shift (ppm) 
HNMR spectra analysis (Table 1 and 
Figure 1). 
 
Table 1: Assignments of 1H NMR chemical shift (ppm) of PCO-C 
(diesters of 4-methoxycinnamic acid) 
Assignments 
7.62 8 (d, 1 H, 16 Hz) 
7.45 5, 3 (m, 2 H) 
6.85 6, 2 (m, 2 H) 
6.33 9 (d, 1H, 16Hz) 
3.83, 3.90 7 (s, 3H) 
 
 
Fig. 1: (A) 1HNMRSpectra of PCO-C (Expansion δ 3.32 - 8.08, CDCl3, 500.13 MHz) and (B) Structure of the diesterof4-methoxycinnamic 
 
acid. 
A toxicology study of the PCO-C (diesters of 4-methoxycinnamic 
acid) was performed and, it was concluded that the maximum safe 
dose of PCO-C was 2000 mg/kg b.w. For the study of the PCO-C 
hypoglycemic effect, a range of 50-500 mg/kg b.w. Was used and the 
results showed that 100 and 150 mg/kg b.w. Doses had 
hypoglycemic action similar to the action of the reference drug 
(glibenclamide). The results of acute toxicity tests with mice showed 
that orally administration of PCO-C doses up to 2000mg/kg did not 
cause any adverse effects or mortality. The present study clearly 
indicates that the PCO-C (diesters of the 4-methoxycinnamic 
acid)has hypoglycemic effect on alloxan induced diabetic mice 
(Table 2). The administration of the PCO-C to diabetic mice resulted 
in a significant decrease (p< 0.05)in the blood glucose levels. It was 
found that 100 mg/Kg b.w. and 150 mg/kg b.w. Doses of PCO-C 
result in 30.5%and 41.5% blood glucose reduction, respectively. In 
the PCO-C treated mice, hypoglycemic effect was evident from the 
Rodrigues et al. 
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10th day onwards; the decrease in blood glucose levels was highly 
pronounced on the 21st day. The hypoglycemic effect of PCO-C at 
150 mg/kg b.w. dose was more prominent than glibenclamide. 
DISCUSSION  
According with the results of previously work [17, 18]and upon 
spectroscopic analysis including FTIR, 1HNMR and melting point, the 
yellowish solid named PCO-C was characterized as esters of the 4-
methoxycinnamic acid (fig. 1b). Ith
The PCO-C was effective in decrease blood glucose levels of diabetic 
mice. Previous studies have shown that substances with similar 
chemical structure to esters of cinnamic acid, such as the gamma-
oryzanol and the policosanol, possess antioxidant, hypolipidemic 
and hypoglycemic properties [23-26]. The gamma-oryzanol, an 
important phytochemical of the rice brain, is a complex mixture of 
esters of the ferulic acid with triterpenic alcohols and sterols[27-29]. 
Study showed hypoglycemic effect of gamma-oryzanol on diabetic 
patients. This compound was able to reduce the concentration of 
fasting blood glucose in 29% and 33% of the patients with DM1 and 
DM2, respectively [30].   
 as been reasonably well 
established that these substituted cinnamic acids occur 
predominantly as adiesters.  
Policosanol is a complex mixture of long-chain primary alcohols and 
it isolated from the sugarcane wax [25]. Another study
 
 
demonstrated that policosanol significantly reduced LDL - 
cholesterol (27.4% and 28.1%), total cholesterol (27.1% and 27.5%) 
and increased serum levels of HDL - cholesterol (17,6% and 17%) at 
doses of 20 and 40 mg / kg, respectively [26]. 
Table 2: Effect of PCO-C (diester of the 4-methoxycinnamic acid) on blood glucose levels in normal and diabetic mice 
Groups Dose (mg/Kg) 0 Day 10 Days 21 Days 
I Normal control - 98.6 ± 8.1 100.1 ± 9.7 100.1 ± 9.7 
II Diabetic control - 251.4 ± 26.3 241.2 ± 20.6 326.1 ± 31.0
III Diabetic+PCO-C 
* 
100 210.6 ± 23.0 151.7 ± 57.3 146.4 ± 31.8* 
IV Diabetic+PCO-C 
* 
150 234.7 ± 23.7 174.2 ± 30.0 137.2 ± 29.4* 
V Diabetic+Glibenclamide 
* 
10 209.4 ± 33.9 110.8 ± 18.1 147.7 ± 44.1* * 
Values expressed as means ± standard deviation (n=7), P values were analyzed using One-Way ANOVA followed by Newman-Keuls test. *p<0.05, 
when groups III, IV and V compared with diabetic control, i.e. group II. 
 
CONCLUSION 
In conclusion, our results showed that the use of PCO-C (diester of 
the 4-methoxycinnamic acid) has a wide margin of security risk and 
showed hypoglycemic effect in diabetic mice. These results are very 
promising and show that carnauba (Coperniciacerifera Mart), a 
native plant of the Caatinga biome, constitutes a rich source of active 
compounds for the treatment of Diabetes Mellitus. 
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